Every day, Wall Street analysts upgrade some stocks, downgrade others, and "initiate coverage" on a few more. But do these analysts even know what they're talking about? Today, we're taking one high-profile Wall Street pick and putting it …
Pharmaceutical company Actavis Plc announced Monday it has entered into a definitive agreement to acquire Botox maker Allergan Inc. for $66 billion, which will create one of the top 10 global pharmaceutical companies by sales revenue. …
What's behind Allergan's sinking share price? Two things: In anticipation of generic Restasis hitting the market soon, Allergan decided to slash 1,000 jobs to kick off 2018. By doing so, the company hopes to cut costs by $300 million to …
In the video above, they tackle Allergan (AGN) (also in Jim Cramer's AAP portfolio). Cramer actually looks to Chaikin for advice on the stock. "You can't trade them," …
For a second day, Allergan's stock price shot up sharply, and the company issued a curt reply. The company said its board of directors "will carefully review and consider the proposal and pursue the course of action that it believes is in …
If you want a Stock Review on CPRX, FLXN, SUPN, or AGN then come over to http://dailystocktracker.com/register and …
Botox maker Allergan (NYSE: AGN) had a forgettable 2017. The branded pharma giant, after all, lost 22% of its value last year, according to data from S&P Global Market Intelligence. What's behind Allergan's sinking share price? Two …